Indeed, chronic inflammation has been demonstrated to lead to JAK/STAT pathway mutations in other cancers, and upregulation of interleukin-6-mediated STAT3 activation has been reported in BIA-ALCL cell lines [24,42]. This evidence concerns the gene STAT3 and cancer.